We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Roche and Bio-Rad Enter Into Global Quality Control Partnership

By LabMedica International staff writers
Posted on 10 Mar 2021
Print article
Image: Roche and Bio-Rad Enter Into Global Quality Control Partnership (Photo courtesy of Bio-Rad Laboratories)
Image: Roche and Bio-Rad Enter Into Global Quality Control Partnership (Photo courtesy of Bio-Rad Laboratories)
Roche (Basel, Switzerland) and Bio-Rad Laboratories (Hercules, CA, USA) have entered into a global partnership to provide their customers access to Bio-Rad's complete line of InteliQ products and Unity QC data management solutions along with customer training and support services.

Bio-Rad offers a broad range of quality controls covering analytes for immunoassay, chemistry, cardiac assessment, immunology, diabetes, coagulation, hematology, blood gas, drugs-of-abuse, and infectious disease testing. The company’s Unity QC data management solutions connect large peer groups of test systems and assay methods to the Unity Interlaboratory Program, enabling labs to compare their results in real time with over 25,000 other labs worldwide.

Through the global partnership, Roche and Bio-Rad will provide InteliQ products, a range of barcoded, load-and-go quality control tubes that provide efficiencies in workflow, in addition to Bio-Rad’s Unity QC data management solutions. The InteliQ products are designed to help streamline a lab's QC workflow with load-and-go efficiency and Unity QC data management solutions that help to reduce turnaround time and increase a laboratory’s analytical performance.

"We are proud to extend our partnership with Roche offering their customers access to our InteliQ line of quality controls and Unity QC data management solutions," said Dara Wright, Bio Rad Clinical Diagnostics Group EVP & President. "This agreement further strengthens and expands the relationship between Bio-Rad, the world’s leading QC supplier, and a leading diagnostic solutions provider."

Related Links:
Roche
Bio-Rad Laboratories


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The utilization of liquid biopsies in cancer research is a rapidly developing field (Photo courtesy of Lightspring/Shutterstock)

Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis

B-cell lymphoma is the predominant form of cancer affecting the lymphatic system, with about 30% of patients with aggressive forms of this disease experiencing relapse. Currently, the disease’s risk assessment... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more